Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects.

H. W. Nam, V. M. Karpyak, D. J. Hinton, J. R. Geske, A. M.C. Ho, M. L. Prieto, J. M. Biernacka, M. A. Frye, R. M. Weinshilboum, D. S. Choi*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects.'. Together they form a unique fingerprint.

Medicine & Life Sciences